ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,467, issued on Dec. 23, was assigned to IDEAYA BIOSCIENCES INC. (South San Francisco, Calif.).

"2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors" was invented by Muzaffar Alam (South San Francisco, Calif.), Leah Cleary (South San Francisco, Calif.), Melissa Fleury (South San Francisco, Calif.), Zhonghua Pei (South San Francisco, Calif.), Richard Steel (South San Francisco, Calif.), James Sutton (South San Francisco, Calif.), John E. Knox (South San Francisco, Calif.) and Zachary E. R. Newby (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are certain 2-oxoquinazoline derivatives...